EUROPE/MIDDLE EAST/AFRICA

摘要

Pharmaceutical company mithraplans to raise about €50m from a placing of new shares to raise cash to finance the development of two products based on the same hormone. Pre-marketing began on Monday, and is expected to take slightly less time than usual, with a price range expected in the week beginning June 15. ING and KBC are joint global coordinators and joint bookrunners. The company specialises in female health, especially the areas of fertility and menopause.